Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight

Symbols: TEVA
Share

Morgan Stanley has downgraded Teva Pharmaceutical (NASDAQ: TEVA) from Overweight to Equal-weight and maintains its $47 price target.


 
 
< Previous
Miller Tabak Downgrades Buffalo Wild Wings to Hold
Next >
UPDATE: Citigroup Downgrades Cbeyond to Neutral
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust